Accuracy of the InnowaveDX MTB/RIF test for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre study

References

• Dara M, Acosta CD, Melchers NV, et al. Tuberculosis control in prisons: current situation and research gaps. Int J Infect Dis. 2015 Mar;32:111–117.
   PubMed Web of Science ®Google Scholar
• World Health Organization. (2021). Global tuberculosis report 2021. https://apps.who.int/iris/handle/10665/346387 [Licence: CC BY-NC-SA 3.0 IGO].
   Google Scholar
• Huo F, Zhang F, Xue Y, et al. Increased prevalence of levofloxacin-resistant Mycobacterium tuberculosis in China is associated with specific mutations within the gyrA gene. Int J Infect Dis. 2020 Mar;92:241–246.
   PubMed Web of Science ®Google Scholar
• Lange C, Chesov D, Heyckendorf J, et al. Drug-resistant tuberculosis: an update on disease burden, diagnosis and treatment. Respirology. 2018 Jul;23(7):656–673.
   PubMed Web of Science ®Google Scholar
• Steingart KR, Henry M, Ng V, et al. Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis. 2006 Sep;6(9):570–581.
   PubMed Web of Science ®Google Scholar
• Styrt BA, Shinnick TM, Ridderhof JC, et al. Turnaround times for mycobacterial cultures. J Clin Microbiol. 1997 Apr;35(4):1041–1042.
   PubMed Web of Science ®Google Scholar
• Votintseva AA, Bradley P, Pankhurst L, et al. Same-day diagnostic and surveillance data for tuberculosis via whole-genome sequencing of direct respiratory samples. J Clin Microbiol. 2017 May;55(5):1285–1298.
   PubMed Web of Science ®Google Scholar
• MacLean E, Kohli M, Weber SF, et al. Advances in molecular diagnosis of tuberculosis. J Clin Microbiol. 2020 Sep 22;58(10):e01582-19.
   PubMed Web of Science ®Google Scholar
• Hanrahan CF, Haguma P, Ochom E, et al. Implementation of Xpert MTB/RIF in Uganda: missed opportunities to improve diagnosis of tuberculosis. Open Forum Infect Dis. 2016 Mar;3(2):ofw068.
   PubMed Web of Science ®Google Scholar
• Albert H, Nathavitharana RR, Isaacs C, et al. Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: what lessons have we learnt and how can we do better? Eur Respir J. 2016 Aug;48(2):516–525.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Rapid implementation of the Xpert MTB/RIF diagnostic test: technical and operational ‘how to’ practical considerations. Geneva: World Health Organization; 2011; https://apps.who.int/iris/handle/10665/44593.
   Google Scholar
• Langley I, Lin HH, Egwaga S, et al. Assessment of the patient, health system, and population effects of Xpert MTB/RIF and alternative diagnostics for tuberculosis in Tanzania: an integrated modelling approach. Lancet Glob Health. 2014 Oct;2(10):e581–e591.
   PubMed Web of Science ®Google Scholar
• Chakravorty S, Simmons AM, Rowneki M, et al. The New Xpert MTB/RIF ultra: improving detection of Mycobacterium tuberculosis and resistance to rifampin in an assay suitable for point-of-care testing. mBio. 2017 Aug 29;8(4):e00812-17.
   PubMed Web of Science ®Google Scholar
• The Ministry of Health, China Center for Disease Control and Prevention. Guidelines for the implementation of China’s tuberculosis control program. Beijing: China Peking Union Medical College Press; 2008.
   Google Scholar
• Seki M, Kim CK, Hayakawa S, et al. Recent advances in tuberculosis diagnostics in resource-limited settings. Eur J Clin Microbiol Infect Dis. 2018 Aug;37(8):1405–1410.
   PubMed Web of Science ®Google Scholar
• Helb D, Jones M, Story E, et al. Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol. 2010 Jan;48(1):229–237.
   PubMed Web of Science ®Google Scholar
• Hohnadel M, Felden L, Fijuljanin D, et al. A new ultrasonic high-throughput instrument for rapid DNA release from microorganisms. J Microbiol Methods. 2014 Apr;99:71–80.
   PubMed Web of Science ®Google Scholar
• Bollet C, Gevaudan MJ, de Lamballerie X, et al. A simple method for the isolation of chromosomal DNA from gram positive or acid-fast bacteria. Nucleic Acids Res. 1991 Apr 25;19(8):1955.
   PubMed Web of Science ®Google Scholar
• Kennedy N, Gillespie SH, Saruni AO, et al. Polymerase chain reaction for assessing treatment response in patients with pulmonary tuberculosis. J Infect Dis. 1994 Sep;170(3):713–716.
   PubMed Web of Science ®Google Scholar
• Mifflin TE. Setting up a PCR laboratory. CSH Protoc. 2007;2007:pdb top14.
   PubMedGoogle Scholar
• Huo F, Ma Y, Liu R, et al. Interpretation of discordant rifampicin susceptibility test results obtained using GeneXpert vs phenotypic drug susceptibility testing. Open Forum Infect Dis. 2020 Aug;7(8):ofaa279.
   PubMed Web of Science ®Google Scholar
• Lawn SD, Mwaba P, Bates M, et al. Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test. Lancet Infect Dis. 2013 Apr;13(4):349–361.
   PubMed Web of Science ®Google Scholar
• Mokaddas EM, Ahmad S, Eldeen HS. Genexpert MTB/RIF Is superior to BBD Max MDR-TB for diagnosis of tuberculosis (TB) in a country with Low incidence of multidrug-resistant TB (MDR-TB). J Clin Microbiol. 2019 Jun;57(6):e00537-19.
   PubMed Web of Science ®Google Scholar
• Liu Z, Dong H, Wu B, et al. Is rifampin resistance a reliable predictive marker of multidrug-resistant tuberculosis in China: a meta-analysis of findings. J Infect. 2019 Oct;79(4):349–356.
   PubMed Web of Science ®Google Scholar
• Fomukong N, Beggs M, el Hajj H, et al. Differences in the prevalence of IS6110 insertion sites in Mycobacterium tuberculosis strains: low and high copy number of IS6110. Tuber Lung Dis. 1997;78(2):109–116.
   PubMedGoogle Scholar
• World Health Organization. Meeting report: High-priority target product profiles for new tuberculosis diagnostics. World Health Organization. 2014. https://www.who.int/publications-detail-redirect/WHO-HTM-TB-2014.18.
   Google Scholar